As you may know psychedelics including psilocybin (magic mushrooms) and MDMA (ecstasy) are legally prescribable in Australia. This often then brings about the next obvious question which is “How much does psychedelic therapy cost“, click on the link to explore how much does psychedelic therapy cost around the world or just watch the video.
The cost of psychedelic therapy can range significantly—from $3,000 to $15,000 USD—depending on a variety of factors. These include the legal status of psychedelics in the country, whether the treatment is administered by a licensed medical professional, and whether the sessions are conducted in individual or group settings. Other considerations such as the number of integration sessions, type of substance used (MDMA vs. psilocybin), and duration of therapy also play a role in shaping the overall expense.
However, this article specifically focuses on answering the question: How much does it cost to access MDMA-assisted therapy in Australia?
Firstly, it’s important to understand why this information isn’t easily accessible. In Australia, the government relies on the Therapeutic Goods Administration (TGA) to regulate medicines and therapeutic interventions. While the TGA has rescheduled psilocybin and MDMA for specific mental health conditions under authorized prescriber schemes, it does not directly regulate the cost of care. Pricing is instead left to the discretion of individual psychiatrists and clinics, who again are restricted from advertising openly online.
Why Is Pricing So Variable?
The variation in pricing largely stems from the unique setup required for psychedelic-assisted therapy. Unlike conventional medication that can be taken at home, MDMA therapy typically involves extended psychotherapy sessions with two trained professionals, often over multiple hours. This includes preparatory sessions, the dosing session itself (which can last 6–8 hours), and multiple integration sessions afterward. The need for specialized training, clinical infrastructure, and compliance with regulatory oversight further increases costs.
Another factor is the limited number of psychiatrists currently authorized to prescribe MDMA under the TGA scheme. As of now, only a small group (<20) of psychiatrists have been approved, and demand is outpacing availability. This scarcity often drives prices higher, particularly in metropolitan areas where clinics are just beginning to offer services.
The Hidden Costs: Training, Licensing, and Infrastructure
It’s also worth noting that providers themselves face substantial costs. Clinics must invest in therapist training—often requiring internationally recognized certification programs—as well as in safety protocols, facility upgrades, insurance, and legal compliance. These costs are typically passed on to the patient in the form of session fees.
Unlike in countries where psychedelic treatment may be covered under public healthcare (such as some pilot trials in Canada or the U.S. under MAPS), Australia’s public healthcare system (Medicare) does not currently reimburse for psychedelic-assisted therapy. This makes the entire cost out-of-pocket, limiting access to those with sufficient financial means.
Summary of Costs in Australia
While individual pricing varies, an estimated breakdown for MDMA therapy in Australia might look like:
- Initial intake and assessment: $200–$500 AUD
- Preparation sessions (2–3 sessions): $500–$1,200 AUD
- MDMA dosing session (1 session): $1,500–$3,000 AUD
- Integration sessions (2–3 sessions): $500–$1,200 AUD
- Total estimated cost per round of therapy: $3,000–$6,000 AUD
Some clinics may charge more depending on the number of therapists present, the prestige or seniority of the psychiatrist, or the level of ongoing care provided.
If you would like more detailed information please contact us.